Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Lin

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Heliyon|March 19, 2024
Comparison of RT-PCR and antigen test sensitivity across nasopharyngeal, nares, and oropharyngeal swab, and saliva sample types during the SARS-CoV-2 omicron variantGregory L Damhorst, Jessica Lin, Jennifer K Frediani, et al.
Plos One|March 27, 2014
Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trialChanthap Lon, Jessica E Manning, Pattaraporn Vanachayangkul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2017
Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue InfectionShu-Wen Wan, Pei-Wei Chen, Chin-Yu Chen, et al.
The Journal of Experimental Medicine|July 9, 2014
Differential roles of microglia and monocytes in the inflamed central nervous systemRyo Yamasaki, Haiyan Lu, Oleg Butovsky, et al.
Open Forum Infectious Diseases|October 30, 2019
Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant <i>P. falciparum</i> Malaria in Cambodia: An Open-Label Randomized TrialMariusz Wojnarski, Chanthap Lon, Pattaraporn Vanachayangkul, et al.
The Lancet. Microbe|August 23, 2021
Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort studyHo Kwong Li, Myrsini Kaforou, Jesus Rodriguez-Manzano, et al.
Iscience|December 6, 2021
Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamstersBryan D Griffin, Bryce M Warner, Mable Chan, et al.
JTO Clinical and Research Reports|October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or CemiplimabBiagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
Neurology|March 22, 2022
Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal StudyJennifer A Frontera, Dixon Yang, Chaitanya Medicherla, et al.
Journal of the Neurological Sciences|May 17, 2021
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complicationsJennifer A Frontera, Dixon Yang, Ariane Lewis, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Heliyon|March 19, 2024
Comparison of RT-PCR and antigen test sensitivity across nasopharyngeal, nares, and oropharyngeal swab, and saliva sample types during the SARS-CoV-2 omicron variantGregory L Damhorst, Jessica Lin, Jennifer K Frediani, et al.
Plos One|March 27, 2014
Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trialChanthap Lon, Jessica E Manning, Pattaraporn Vanachayangkul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2017
Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue InfectionShu-Wen Wan, Pei-Wei Chen, Chin-Yu Chen, et al.
The Journal of Experimental Medicine|July 9, 2014
Differential roles of microglia and monocytes in the inflamed central nervous systemRyo Yamasaki, Haiyan Lu, Oleg Butovsky, et al.
Open Forum Infectious Diseases|October 30, 2019
Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant <i>P. falciparum</i> Malaria in Cambodia: An Open-Label Randomized TrialMariusz Wojnarski, Chanthap Lon, Pattaraporn Vanachayangkul, et al.
The Lancet. Microbe|August 23, 2021
Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort studyHo Kwong Li, Myrsini Kaforou, Jesus Rodriguez-Manzano, et al.
Iscience|December 6, 2021
Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamstersBryan D Griffin, Bryce M Warner, Mable Chan, et al.
JTO Clinical and Research Reports|October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or CemiplimabBiagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
Neurology|March 22, 2022
Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal StudyJennifer A Frontera, Dixon Yang, Chaitanya Medicherla, et al.
Journal of the Neurological Sciences|May 17, 2021
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complicationsJennifer A Frontera, Dixon Yang, Ariane Lewis, et al.
Pageof 17